Security
America Great Health Common Stock · AAGH
AAGHOTCCommon stockCurrentCIK 1098009Updated Oct 27, 2026
Name history
CROWN MARKETING · through May 17, 2017SPACE LAUNCHES FINANCING INC · through Sep 9, 2011
AAGH price & chart
Loading TradingView…
OTC:AAGH on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
NT 10-K filing
Other Events
Items 8.01, 9.01
10-Q filing
10-Q filing
10-Q filing
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 167,105Source | 266,993Source | 333,390Source | 193,105Source | 281,630Source | 323,610Source | 241,296Source | 305,642Source | 301,817Source | 323,478Source | 299,129Source | 336,143Source |
| Property, Plant and Equipment, NetUSD | 203Source | 31,812Source | 46,600Source | 20,720Source | 35,509Source | 50,298Source | 24,417Source | 39,206Source | 28,115Source | 42,903Source | 57,692Source | 23,618Source |
| Current assets: | ||||||||||||
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 0Source | 36,900Source | 69,800Source | 0Source | 36,900Source | 23,400Source | 0Source | 36,900Source | 0Source | 55,100Source | 0Source | 918Source |
| Inventory, NetUSD | 97,539Source | 107,356Source | 133,139Source | 103,909Source | 117,161Source | 133,751Source | 137,874Source | 119,116Source | 164,651Source | 83,141Source | 108,351Source | 116,060Source |
| Assets, CurrentUSD | 145,980Source | 196,192Source | 266,273Source | 145,908Source | 201,696Source | 246,372Source | 185,048Source | 216,642Source | 236,712Source | 225,479Source | 179,465Source | 196,585Source |
| Prepaid Expense and Other Assets, CurrentUSD | 19,095Source | 15,056Source | 11,595Source | 19,095Source | 11,595Source | 16,965Source | 19,095Source | 11,595Source | 28,005Source | 32,295Source | — | — |
| Operating Lease, Right-of-Use AssetUSD | — | — | 3,506Source | — | — | 8,711Source | — | 37,958Source | 25,154Source | 43,260Source | 41,918Source | 93,886Source |
| Other Assets, NoncurrentUSD | 9,086Source | 27,153Source | — | 14,641Source | 32,589Source | — | 19,995Source | 0Source | — | 0Source | 8,218Source | 13,836Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 5,047,740Source | 5,976,602Source | 5,207,174Source | 4,908,221Source | 5,858,007Source | 5,101,878Source | 6,070,405Source | 5,694,913Source | 6,045,644Source | 5,635,077Source | 4,824,965Source | 4,196,624Source |
| Commitments and ContingenciesUSD | — | 0Source | 0Source | — | 0Source | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 5,121,175Source | 5,121,175Source | 5,019,059Source | 5,121,175Source | 5,096,175Source | 4,886,433Source | 5,121,175Source | 5,087,059Source | 5,121,175Source | 5,019,059Source | 4,732,477Source | 4,619,991Source |
| Retained Earnings (Accumulated Deficit)USD | -9,920,040Source | -10,745,604Source | -9,814,337Source | -9,754,024Source | -10,587,205Source | -9,587,788Source | -10,866,708Source | -10,394,085Source | -10,781,345Source | -10,248,681Source | -9,183,110Source | -8,421,849Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 1,047Source | -2,563Source | -197Source | 350Source | -2,708Source | -563Source | -959Source | -188Source | -1,040Source | -1,483Source | -500Source | 160Source |
| Stockholders' Equity Attributable to ParentUSD | -4,797,818Source | -5,626,992Source | -4,795,475Source | -4,632,499Source | -5,493,738Source | -4,701,918Source | -5,746,492Source | -5,307,214Source | -5,661,210Source | -5,231,105Source | -4,451,133Source | -3,801,698Source |
| Liabilities and EquityUSD | 167,105Source | 266,993Source | 333,390Source | 193,105Source | 281,630Source | 323,610Source | 241,296Source | 305,642Source | 301,817Source | 323,478Source | 299,129Source | 336,143Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 2,624,391Source | 3,708,534Source | 3,254,367Source | 2,550,123Source | 3,698,121Source | 3,221,529Source | 3,779,008Source | 3,594,166Source | 3,820,947Source | 3,593,468Source | 3,091,935Source | 2,757,422Source |
| Operating Lease, Liability, CurrentUSD | 9,086Source | 5,576Source | 3,506Source | 14,641Source | 11,012Source | 8,711Source | 19,995Source | 16,381Source | 25,154Source | 21,683Source | 41,918Source | 70,895Source |
| Operating Lease, Liability, NoncurrentUSD | 0Source | 21,577Source | 0Source | 0Source | 21,577Source | 0Source | 0Source | 21,577Source | 0Source | 21,577Source | 0Source | 22,991Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -82,817Source | -82,617Source | -78,309Source | -82,617Source | -82,639Source | -76,350Source | -82,617Source | -82,057Source | -82,617Source | -80,494Source | -74,703Source | -58,783Source |
| Additional Financial Items | ||||||||||||
| Deferred Revenue, CurrentUSD | — | — | 214,600Source | — | — | 217,747Source | — | — | — | — | 223,331Source | 157,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 2,423,349Source | 2,224,697Source | 1,123,138Source | 2,358,098Source | 1,951,854Source | 1,123,138Source | 2,291,397Source | 1,892,715Source | 2,224,697Source | 1,833,577Source | 1,123,138Source | 1,032,138Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 2,423,349Source | 2,060,036Source | 1,123,138Source | 2,358,098Source | 1,951,854Source | 1,123,138Source | 2,291,397Source | 1,892,715Source | 2,224,697Source | 1,833,577Source | 1,123,138Source | 1,032,138Source |
| Accounts Payable, Current | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
| Accounts Receivable, after Allowance for Credit Loss | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -166,216Source | -158,377Source | 1,112,684Source | -193,702Source | -85,363Source | -146,967Source | -721,242Source | -1,226,362Source | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | — | 0Source | 123,582Source | 0Source | 1,361,133Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 0Source | -18,200Source | -55,100Source | 55,100Source | -919Source | 918Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -26,777Source | 35,975Source | 81,110Source | -15,810Source | -7,709Source | 108,211Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 44,466Source | -95,578Source | -332,862Source | -615,627Source | -752,902Source | -1,479,858Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | -44,420Source | -16,851Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | — | — | 0Source | 44,420Source | 16,851Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -60,524Source | 88,371Source | 321,532Source | 617,403Source | 789,328Source | 1,163,056Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | 10,000Source | 0Source | 10,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 29,346Source | 36,880Source | 22,904Source | 36,040Source | 28,079Source | 49,031Source | 44,056Source | 54,943Source | 54,150Source | 62,643Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | 61,277Source | 76,403Source | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 81Source | 1,295Source | 443Source | -983Source | -499Source | 160Source |
| Additional Financial Items | ||||||||||||
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 0Source |
| DepreciationUSD | — | — | — | — | — | — | 3,698Source | 3,697Source | 14,788Source | 14,789Source | 10,346Source | 5,905Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | — | — | 500Source | -160Source |
| General and Administrative ExpenseUSD | — | — | 90,422Source | 120,881Source | 203,797Source | 195,155Source | 95,251Source | 184,912Source | 671,190Source | 856,615Source | 657,233Source | 3,163,977Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 0Source |
| InterestExpenseNonoperatingUSD | — | — | 83,905Source | 73,059Source | 83,545Source | 73,208Source | 81,982Source | 76,127Source | 338,353Source | 443,723Source | — | — |
| Investment Income, InterestUSD | — | — | — | 1Source | — | 20Source | 3Source | 19Source | 46Source | 61Source | 26Source | 5Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -166,016Source | -158,399Source | 1,112,684Source | -193,120Source | -85,363Source | -145,404Source | -719,119Source | -1,220,571Source | -777,340Source | -4,924,936Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -200Source | 22Source | 0Source | -582Source | 0Source | -1,563Source | -2,123Source | -5,791Source | -15,920Source | -58,783Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -761,420Source | -4,866,153Source |
| Nonoperating Income (Expense)USD | — | — | -92,441Source | -73,058Source | 1,311,459Source | -73,188Source | -81,979Source | -76,108Source | -338,307Source | -443,662Source | -284,696Source | -190,838Source |
| Operating Lease, ExpenseUSD | — | — | 20,674Source | — | 20,674Source | — | 20,674Source | 20,639Source | 82,578Source | 80,438Source | 36,556Source | 33,041Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 0Source | 68,000Source | 102,116Source | 115,000Source | 92,080Source | 97,500Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | 10,000Source | 150,000Source | 60,000Source | 324,682Source | 639,734Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Income Tax Expense (Benefit) | — | — | — | —Source | — | —Source | —Source | —Source | — | — | — | — |
| Operating Costs and Expenses | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Other Nonoperating Income (Expense) | — | — | —Source | —Source | — | — | — | — | — | — | — | — |
| Other Operating Income (Expense), Net | — | — | —Source | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | — | — | — | — | — | — | 391,743Source | 294,670Source | 204,308Source | 104,648Source |
| Cost of RevenueUSD | — | — | 3,610Source | 6,331Source | 8,564Source | 7,842Source | 74,880Source | 11,335Source | 52,622Source | 124,920Source | 35,720Source | 1,588,453Source |
| Selling, General and Administrative ExpenseUSD | — | — | 96,308Source | 135,136Source | 235,311Source | 203,611Source | 116,063Source | 199,650Source | 722,056Source | 952,450Source | 661,232Source | 3,250,293Source |
| Operating Income (Loss)USD | — | — | -73,775Source | -85,319Source | -198,775Source | -120,514Source | -3,384Source | -70,859Source | -382,935Source | -782,700Source | -492,644Source | -4,734,098Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -166,216Source | -158,377Source | 1,112,684Source | -193,702Source | -85,363Source | -146,967Source | -721,242Source | -1,226,362Source | -777,340Source | -4,924,936Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -200Source | 22Source | 0Source | -582Source | 0Source | -1,563Source | -2,123Source | -5,791Source | -15,920Source | -58,783Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -166,016Source | -158,399Source | 1,112,684Source | -193,120Source | -85,363Source | -145,404Source | -719,119Source | -1,220,571Source | -777,340Source | -4,924,936Source |
| Earnings Per Share, BasicUSD per share | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — | — |
| Earnings Per Share, DilutedUSD per share | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 21,152,711,608Source | 21,150,711,608Source | 21,152,711,608Source | 21,137,188,832Source | 21,152,711,608Source | 21,136,888,326Source | 21,144,246,300Source | 21,123,253,567Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 21,152,711,608Source | 21,150,711,608Source | 21,152,711,608Source | 21,137,188,832Source | — | — | 21,144,246,300Source | 21,123,253,567Source | — | — |
| Interest Expense (non-operating)USD | — | — | 83,905Source | 73,059Source | 83,545Source | 73,208Source | 81,982Source | 76,127Source | 338,353Source | 443,723Source | — | — |
| Additional Financial Items | ||||||||||||
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | — | — | — | — | — | — | — | — | 500Source | -160Source |
| General and Administrative ExpenseUSD | — | — | 90,422Source | 120,881Source | 203,797Source | 195,155Source | 95,251Source | 184,912Source | 671,190Source | 856,615Source | 657,233Source | 3,163,977Source |
| Gross ProfitUSD | — | — | 22,533Source | 49,817Source | 36,536Source | 83,097Source | 112,679Source | 128,791Source | 339,121Source | 169,750Source | 168,588Source | -1,483,805Source |
| Income (Loss) from Equity Method InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 319,705Source | 190,916Source |
| Interest Expense, DebtUSD | — | — | — | — | — | — | 968,259Source | 719,577Source | 901,559Source | 660,439Source | 402,458Source | 189,754Source |
| Investment Income, InterestUSD | — | — | — | 1Source | — | 20Source | 3Source | 19Source | 46Source | 61Source | 26Source | 5Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -761,420Source | -4,866,153Source |
| Nonoperating Income (Expense)USD | — | — | -92,441Source | -73,058Source | 1,311,459Source | -73,188Source | -81,979Source | -76,108Source | -338,307Source | -443,662Source | -284,696Source | -190,838Source |
| Operating Lease, ExpenseUSD | — | — | 20,674Source | — | 20,674Source | — | 20,674Source | 20,639Source | 82,578Source | 80,438Source | 36,556Source | 33,041Source |
| Other IncomeUSD | — | — | — | — | — | — | — | — | — | 0Source | 34,983Source | 73Source |
| Selling ExpenseUSD | — | — | — | — | — | 8,456Source | — | 14,738Source | 50,866Source | 95,835Source | 3,999Source | 86,316Source |
| Total Revenue | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Other Nonoperating Income (Expense) | — | — | —Source | —Source | — | — | — | — | — | — | — | — |
| Income Tax Expense (Benefit) | — | — | — | —Source | — | —Source | —Source | —Source | — | — | — | — |
| Operating Costs and Expenses | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Other Operating Income (Expense), Net | — | — | —Source | — | — | — | — | — | — | — | — | — |
Filing attachments
aaghex99-1.htm · 8-K · 2026-08-24
EX-99.1 2 aaghex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Zhejiang Kangjing Hospital Clinical Trial Report Evaluation of a Clinical Observational Study of Ion-Modified Peptides as Adjunctive Therapy for Solid Tumors Study Document period status December 2024–May 2026 Interim Summary ─────────────────────────────────────────────── I. Investigational Products, Methods, and Dosages A. Investigational products AX-3 (Ion Peptide No. 1) and PP…
Read attachment ↗aaghex99-2.htm · 8-K · 2026-08-24
EX-99.2 3 aaghex99-2.htm EXHIBIT 99.2 Exhibit 99.2 1. Clinical Efficacy of Ion-Peptide Adjunctive Therapy in Patients with Solid Tumors No. Name Sex Age Diagnosis Before 1 …
Read attachment ↗